BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21238887)

  • 21. Modelling the outcomes of different red blood cell transfusion strategies for the treatment of traumatic haemorrhage in the prehospital setting in the United Kingdom.
    Roberts B; Green L; Ahmed V; Latham T; O'Boyle P; Yazer MH; Cardigan R
    Vox Sang; 2022 Nov; 117(11):1287-1295. PubMed ID: 36102164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood component therapy: differential indication for erythrocyte transfusion].
    Bergmann H
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):184-9. PubMed ID: 7191413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.
    Zeuner A; Martelli F; Vaglio S; Federici G; Whitsett C; Migliaccio AR
    Stem Cells; 2012 Aug; 30(8):1587-96. PubMed ID: 22644674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red blood cell engineering in stroma and serum/plasma-free conditions and long term storage.
    Kim HO; Baek EJ
    Tissue Eng Part A; 2012 Jan; 18(1-2):117-26. PubMed ID: 21902543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion practice in massively bleeding patients: time for a change?
    Johansson PI; Hansen MB; Sørensen H
    Vox Sang; 2005 Aug; 89(2):92-6. PubMed ID: 16101690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies.
    Long C; Hara H; Pawlikowski Z; Koike N; d'Arville T; Yeh P; Ezzelarab M; Ayares D; Yazer M; Cooper DK
    Transfusion; 2009 Nov; 49(11):2418-29. PubMed ID: 19624491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods.
    Luten M; Roerdinkholder-Stoelwinder B; Schaap NP; de Grip WJ; Bos HJ; Bosman GJ
    Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research advance on universal red blood cell engineering].
    Tan YX; Ji SP; Gong F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):814-9. PubMed ID: 21729578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood management in intensive care medicine: CRIT and ABC--what can we learn?
    Spahn DR; Marcucci C
    Crit Care; 2004 Apr; 8(2):89-90. PubMed ID: 15025763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From stem cell to red blood cells in vitro: "the 12 labors of Hercules".
    Douay L
    Clin Lab Med; 2010 Jun; 30(2):391-403. PubMed ID: 20513558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
    Benjamin RJ; McCullough J; Mintz PD; Snyder E; Spotnitz WD; Rizzo RJ; Wages D; Lin JS; Wood L; Corash L; Conlan MG
    Transfusion; 2005 Nov; 45(11):1739-49. PubMed ID: 16271099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of red blood cells on hemostasis.
    Roeloffzen WW; Kluin-Nelemans HC; Bosman L; de Wolf JT
    Transfusion; 2010 Jul; 50(7):1536-44. PubMed ID: 20158685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of babesiosis on transfusion medicine.
    Pantanowitz L; Telford SR; Cannon ME
    Transfus Med Rev; 2002 Apr; 16(2):131-43. PubMed ID: 11941575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of Red Blood Cells from Human Pluripotent Stem Cells-An Update.
    Lee SJ; Jung C; Oh JE; Kim S; Lee S; Lee JY; Yoon YS
    Cells; 2023 Jun; 12(11):. PubMed ID: 37296674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stored erythrocytes have less capacity than normal erythrocytes to support primary haemostasis.
    Reinhart WH; Zehnder L; Schulzki T
    Thromb Haemost; 2009 Apr; 101(4):720-3. PubMed ID: 19350117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
    Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
    Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation.
    Webert KE; Cook RJ; Couban S; Carruthers J; Lee KA; Blajchman MA; Lipton JH; Brandwein JM; Heddle NM
    Transfusion; 2008 Jan; 48(1):81-91. PubMed ID: 17894791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.